Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Representational similarity analysis of neural patterns in childhood maltreatment
    Published on 2024-08-03
    2 years ago
  • Developmental neuroplasticity and adversity-related risk for psychopathology
    Published on 2024-08-02
    2 years ago
  • The promise of precision functional mapping for neuroimaging in psychiatry
    Published on 2024-07-31
    2 years ago
  • Therapeutic effects of extinction require hippocampal input and BDNF signaling in IL
    Published on 2024-07-31
    2 years ago
  • Punishment-resistant alcohol intake is mediated by the nucleus accumbens shell in female rats
    Published on 2024-07-29
    2 years ago
  • Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants
    Published on 2024-07-26
    2 years ago
  • Human neuroimaging and antipsychotic neurobiology at millisecond temporal resolution
    Published on 2024-07-26
    2 years ago
« Previous 1 … 88 89 90 91 92 … 143 Next »
Journal of Psychopharmacology
  • Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning
    Published on 2022-03-04
    5 years ago
  • Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ)
    Published on 2022-03-02
    5 years ago
  • The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
    Published on 2022-02-25
    5 years ago
  • Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine
    Published on 2022-02-25
    5 years ago
  • A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults
    Published on 2022-02-15
    5 years ago
  • LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking
    Published on 2022-02-02
    5 years ago
  • Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
    Published on 2022-02-02
    5 years ago
« Previous 1 … 88 89 90 91 92 … 154 Next »
European Neuropsychopharmacology
  • The time to act: early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´s letter to the editor (Llach and Anmella 2022)
    Published on 2022-05-21
    4 years ago
  • Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder
    Published on 2022-05-11
    4 years ago
  • Social Stress in Bipolar Disorder
    Published on 2022-05-11
    4 years ago
  • Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology
    Published on 2022-05-11
    4 years ago
  • Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials – Challenges and future perspectives. A critical review
    Published on 2022-05-11
    4 years ago
  • Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)
    Published on 2022-05-10
    4 years ago
  • Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
    Published on 2022-05-10
    4 years ago
« Previous 1 … 88 89 90 91 92 … 170 Next »

   Pharma Pub